1. B7-H4 is a prognostic biomarker for poor survival in patients with pancreatic cancer
    Lingwei Shen et al, 2017, Human Pathology CrossRef
  2. Immune checkpoint therapy for pancreatic cancer
    Henrik Johansson et al, 2016, WJG CrossRef
  3. Undifferentiated Pancreatic Carcinomas Display Enrichment for Frequency and Extent of PD-L1 Expression by Tumor Cells
    Heidi D Lehrke et al, 2017 CrossRef
  4. Immunotherapy in pancreatic cancer treatment: a new frontier
    Komal Thind et al, 2017, Therap Adv Gastroenterol CrossRef
  5. IFNγ induces PD-L1 overexpression by JAK2/STAT1/IRF-1 signaling in EBV-positive gastric carcinoma
    Ji Wook Moon et al, 2017, Sci Rep CrossRef
  6. Immune Evasion in Pancreatic Cancer: From Mechanisms to Therapy
    Neus Martinez-Bosch et al, 2018, Cancers CrossRef
  7. Clinical relevance of expression of B7-H1 and B7-H4 in ovarian cancer
    MEI XU et al, 2016 CrossRef
  8. The clinicopathological and prognostic significance of PD-L1 expression in pancreatic cancer: a meta-analysis
    He-Li Gao et al, 2018, Hepatobiliary & Pancreatic Diseases International CrossRef
  9. Control of PD-L1 expression by miR-140/142/340/383 and oncogenic activation of the OCT4–miR-18a pathway in cervical cancer
    Peixin Dong et al, 2018, Oncogene CrossRef
  10. Comprehensive molecular profiling of the B7 family in gastrointestinal cancer
    Qijie Zhao et al, 2018, Cell Prolif CrossRef
  11. Pancreatic-cancer-cell-derived trefoil factor 2 impairs maturation and migration of human monocyte-derived dendritic cells in vitro
    Gi-Ho Sung et al, 2018, Animal Cells and Systems CrossRef
  12. Cancer immunotherapy using PolyPurine Reverse Hoogsteen hairpins targeting the PD-1/PD-L1 pathway in human tumor cells.
    Carlos J. Ciudad, 0 CrossRef
  13. Reverse signaling via PD-L1 supports malignant cell growth and survival in classical Hodgkin lymphoma
    Shahrzad Jalali et al, 2019, Blood Cancer Journal CrossRef
  14. Thyroid hormone-induced expression of inflammatory cytokines interfere with resveratrol-induced anti-proliferation of oral cancer cells
    Yi-Ru Chen et al, 2019, Food and Chemical Toxicology CrossRef
  15. PD-1 and PD-L1 blockade in gastrointestinal malignancies
    Hazel Lote et al, 2015, Cancer Treatment Reviews CrossRef
  16. CD274 promotes cell cycle entry of leukemia-initiating cells through JNK/Cyclin D2 signaling
    Xia Fang et al, 2016, J Hematol Oncol CrossRef
  17. Herbal Medicines Attenuate PD-L1 Expression to Induce Anti-Proliferation in Obesity-Related Cancers
    Yu-Chen S.H. Yang et al, 2019, Nutrients CrossRef
  18. NDAT suppresses pro-inflammatory gene expression to enhance resveratrol-induced anti-proliferation in oral cancer cells
    Yih Ho et al, 2019, Food and Chemical Toxicology CrossRef
  19. Prognostic value of PDL1 expression in pancreatic cancer
    David J. Birnbaum et al, 2016, Oncotarget CrossRef
  20. PD-L1 promotes tumor growth and progression by activating WIP and β-catenin signaling pathways and predicts poor prognosis in lung cancer.
    Wendan Yu et al, 2020, Cell Death Dis CrossRef
  21. Immunotherapeutic strategies in pancreatic ductal adenocarcinoma (PDAC): current perspectives and future prospects
    Zanele Nsingwane et al, 2020, Mol Biol Rep CrossRef
  22. Myeloma Drug Resistance Induced by Binding of Myeloma B7-H1 (PD-L1) to PD-1
    Mariko Ishibashi et al, 2016, Cancer Immunol Res CrossRef
  23. Ex Vivo PD-L1/PD-1 Pathway Blockade Reverses Dysfunction of Circulating CEA-Specific T Cells in Pancreatic Cancer Patients
    Yuan Chen et al, 2017, Clin Cancer Res CrossRef
  24. Envisioning the immune system to determine its role in pancreatic ductal adenocarcinoma: culprit or victim?
    Darya Javadrashid et al, 2021, Immunology Letters CrossRef
  25. Chemoradiation induces upregulation of immunogenic cell death-related molecules together with increased expression of PD-L1 and galectin-9 in gastric cancer
    S. H. Petersen et al, 2021, Sci Rep CrossRef
  26. Gemcitabine Plus Nab-Paclitaxel Induces PD-L1 mRNA Expression in Plasma-Derived Microvesicles in Pancreatic Cancer
    Marzia Del Re et al, 2021, Cancers CrossRef
  27. PKCι regulates the expression of PDL1 through multiple pathways to modulate immune suppression of pancreatic cancer cells
    Hongmei Zhang et al, 2021, Cellular Signalling CrossRef
  28. Construction of a five-gene prognostic model based on immune-related genes for the prediction of survival in pancreatic cancer
    Bo Liu et al, 2021 CrossRef
  29. Checkpoints and Immunity in Cancers: Role of GNG12
    Abdullahi Alausa et al, 2022, Pharmacological Research CrossRef
  30. PAUF Induces Migration of Human Pancreatic Cancer Cells Exclusively via the TLR4/MyD88/NF-κB Signaling Pathway
    So Eun Youn et al, 2022, IJMS CrossRef
  31. Injury activated alveolar progenitors (IAAPs): the underdog of lung repair
    Lei Chong et al, 2023, Cell. Mol. Life Sci. CrossRef